Agitateur, le 22 avril 2011 à 19:59, dit :
Nautilus, ta logique est foudroyante de malhonnêteté.
Sur autisme / maladie coeliaque: tu vas bien vite en besogne.
Quand aux biopsies intestinales, c'est drôle. Je voudrais bien savoir ou tu as bien pu lire çà. Ce serait donc le motif de sa radiation ? Tu te foutrais pas un peu de notre gueule, non ?
Toujours la grande classe quand tu es à cours d' argument
Brian Deer qui a accusé Wakefield dans le BMJ est journaliste ! C 'est lui qui parle de fraude; personne dans le procès n' a parlé de fraude !
Pour ton information l' affaire est sortie plusieurs années après la publication du papier alors que Wakefield avait fait chuté la confiance en la vaccination ROR en UK
Le procès de 2010 ne parle pas de fraude mais de certains éléments de l' article incorrects et non ethiques ( biopsie intestinales)
liens et conflits d' intérêts
le groupe médical reed-elsevier (lancet...) est dirigé par Crispin Davis, qui est directeur non excecutif de Glaxosmithkline
Le frère de crispin Davis est le juge qui a retiré l' assisatnce juduciare aux plaignants (parrents d' enfants autistes fabricants de vaccins)
publications Sur autisme et maladie coeliaque (pour occuper ton wede Pâques)
Afzal N, et al. Constipation with acquired megarectum in children with autism. Pediatrics. 2003 Oct;112(4):939-42.
Arvilommi H, Isolauri E.Kalliomäki M, Poussa T, Salminen S. Probiotics and prevention of atopic disease: 4-year follow-up of a
randomised placebo-controlled trial. Lancet. 2003 361(9372):1869-71.
Ashwood P et al. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopa-
thology. J Clin Immunol. 2003 Nov;23(6):504-17.
Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with
autism and gastrointestinal symptoms. J Neuroimmunol. 2006 Apr;173(1-2):126-34.
Balzola F, Barbon V, Repici A, Rizzetto M. Panenteric IBD-like disease in a patient with regressive autism shown for the first time
by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome? Am J Gastro. 2005; 979-981.
Balzola F, et al. Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients. Gastroen-
terology. 2005;128:Suppl.2;A-303.
Balzola F, et al. Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic
enterocolitis followed over one year. Gastroenterology, April 2006 Vol 130 Number 4 suppl. 2 S1364 A-21.
Billoo AG, Memon MA, Khaskheli SA, et al. Role of probiotic Saccharomyces boulardii in management and prevention of diarrhea.
World J Gastroenterol. 2006;12:4557-4560.
Buie T, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.
Pediatrics. 2010 Jan;125 Suppl 1:S1-18.
Buie T, Fuchs GJ 3rd, Furuta GT, Kooros K, Levy J, Lewis JD, Wershil BK, Winter H. Recommendations for evaluation and
treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010 Jan;125 Suppl 1:S19-29.
Buts JP, De Keyser N. Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci. 2006 Aug;51(:1485-92.
Cade R, et al. Autism and schizophrenia: intestinal disorders. Nutritional Neuroscience 3: 57-72, 2000.
Cade JR, et al. Autism and schizophrenia linked to malfunctioning enzyme for milk protein digestion. Autism, Mar 1999.
Chen B, Girgis S, El-Matary W. Childhood autism and eosinophilic colitis. Digestion. 2010;81(2):127-9.
DeFelice ML, et al. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol 98(: 1777-82:
2003.
del Giudice MM, Brunese FP. Probiotics, prebiotics, and allergy in children: what's new in the last year? J Clin Gastroenterol. 2008
Sep;42 Suppl 3 Pt 2:S205-8.
D'Eufemia P, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996 Sep;85(9):1076-9.
Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis. 2004 May;10(3):286.
Furlano RI, et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. 2001
Mar;138(3):366-72.
Galiatsatos P, et al. Autistic enterocolitis: fact or fiction? Can J Gastroenterol 2009;23(2):95-98.
Genuis SJ, Bouchard TP. Celiac Disease Presenting as Autism. J Child Neurol. 2009 Jun 29.
Gonzalez L, Lopez K, Navarro D, Negron L, Flores L, Rodriguez R, Martinez M, Sabra A. Endoscopic and Histological Characteris-
tics of the digestive mucosa in autistic children with gastrointestinal symptoms. Arch Venez Pueric Pediatr 69;1:19-25
Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr. 2005 Mar;146(3
Suppl):S3-12.
Horvath K et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999 Nov;135(5):559-63.
Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep. 2002 Jun;4(3):251-8.
Horvath K, Perman JA. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. 2002 Oct;14(5):583-7.
Iacono G et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med. 1998 Oct 15;339(16):1100-4.
Işeri SO, Sener G, Sağlam B, Gedik N, Ercan F, Yeğen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-
dependent mechanism. Peptides. 2005 Mar;26(3):483-91.
Kawashima H et al. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory
bowel disease and autism. Dig Dis Sci. 2000 Apr;45(4):723-9.
Kazek B, et al. Platelet and intestinal 5-HT2A receptor mRNA in autistic spectrum disorders – results of a pilot study. Acta Neurobiol
Exp 2010, 70: 232–238.
Koch TR, et al. Induction of enlarged intestinal lymphoid aggregates during acute glutathione depletion in a murine model. Dig Dis
Sci 2000. 45(11): 2115-21.
Kuddo T, Nelson KB. How common are gastrointestinal disorders in children with autism. Curr Opin Pediatr 2003: 15(3); 339-343.
Kushak R, Winter H, Farber N, Buie T. Gastrointestinal symptoms and intestinal disaccharidase activities in children with autism.
Abstract of presentation to the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition, Annual Meet-
ing, October 20-22, 2005, Salt Lake City, Utah.
Levy S, et al. Children with autistic spectrum disorders. I: Comparison of placebo and single dose of human synthetic secretin. Arch.
Dis. Child. 2003;88;731-736.
Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohn's disease. Gastroenterol Nurs. 2006 Jul-Aug;29(4):295-301.
McGinnis WR. Mercury and autistic gut disease. Environ Health Perspect. 2001 Jul;109(7):A303-4.
Melmed RD, Schneider CK, Fabes RA. Metabolic markers and gastrointestinal symptoms in children with autism and related
disorders. J Pediatr Gastroenterol Nutr 2000:31(suppl 2)S31-32.
Nikolov, RN, et al, Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord.
2009 Mar;39(3):405-13.
Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum
disorders and that of healthy children. J Med Microbiol. 2005 Oct;54(Pt 10):987-91.
Quigley EM, Hurley D. Autism and the gastrointestinal tract. Am J Gastroenterol. 2000 Sep;95(9):2154-6.
Reichelt KL, Knivsberg AM. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr
Neurosci. 2003 Feb;6(1):19-28.
Reichelt KL, et al. Probable Etiology and Possible Treatment of Childhood Autism. Brain Dysfuntion 1991; 4: 308-319.
Reichelt KL, Knivsberg AM. The possibility and probability of a gut-to-brain connection in autism. Ann Clin Psychiatry. 2009 Oct-
Dec;21(4):205-11.
Rimland, B. Secretin treatment for autism. N Engl J Med 2000. 342(16): 1216-7; author reply 1218.
Romano C, et al. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric
Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol. 2005 Dec 7;11(45):7118-21.
Sandler RH, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000 Jul;15(7):429.
Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA. Oral Human Immunoglobulin for Children with
Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study. J Autism Dev Disord. 2006 Jul 15.
Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with
inflammatory bowel disease. Gut. 1998 Apr;42(4):485-92.
Sienkiewicz-Szapka E, et al. Transport of bovine milk derived opioid peptides across a Caco-2 monolayer, Int Dairy J. 2008.
Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004
Nov;70(11):6459-65.
Sturniolo, G.C., et al. Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis, 2001. 7(2): p. 94-8.
Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or
developmental regression in children with autism: population study. BMJ. 2002 Feb 16;324(7334):393-6.
Torrente F, Anthony A. Focal-enhanced gastritis in regressive autism with features distinct from Crohn's disease and helicobacter
Pylori gastritis. Am J Gastroenterol 2004 Apr;99(4):598-605.
Torrente F et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol
Psychiatry. 2002;7(4):375-82, 334.
Valicenti-McDermott M, et al. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association
with family history of autoimmune disease. J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S128-36.
Valicenti-McDermott MD, McVicar K, Cohen HJ, Wershil BK, Shinnar S. Gastrointestinal symptoms in children with an autism
spectrum disorder and language regression. Pediatr Neurol. 2008 Dec;39(6):392-8.
Wakefield AJ, Ashwood P, Limb K, Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with
autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005 Aug;17(:827-36.
Wakefield AJ. Enterocolitis, autism and measles virus. Mol Psychiatry. 2002;7 Suppl 2:S44-6.
Wakefield AJ. The gut-brain axis in childhood developmental disorders. J Pediatr Gastroenterol Nutr. 2002 May-Jun;34 Suppl
1:S14-7.
Wakefield AJ et al. Review article: the concept of enterocolonic encephalopathy, autism and opioid receptor ligands. Aliment
Pharmacol Ther 2002 16(4):663-74.
Wakefield AJ, et al. Autism, viral infection and measles-mumps-rubella vaccination. Isr Med Assoc J. 1999 Nov;1(3):183-7.
Wakefield AJ. MMR vaccination and autism. Lancet. 1999 Sep 11;354(9182):949-50.
Welch MG, Welch-Horan TB, Anwar M, Anwar N, Ludwig RJ, Ruggiero DA. Brain effects of chronic IBD in areas abnormal in
autism and treatment by single neuropeptides secretin and oxytocin. J Mol Neurosci 2005; 25(3):259-74.
White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood). 2003 Jun;228(6):639-49.
Whiteley P, Shattock P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new
opportunities for biomedical intervention. Expert Opin Ther Targets. 2002 Apr;6(2):175-83.
Tu veux d' autres publications sur le lien entre maladies coeliaque et autisme regressif ?
Ce message a été modifié par nautilus - 23 avril 2011 à 07:28.